MARF is dedicated to ending the suffering caused by mesothelioma. The Foundation's research grant program offers grants to all levels and degrees of scientists.
2025 Areas of Interest:
- Novel therapies for mesothelioma for both pleural and peritoneal (focus on – targeted therapies, combination immunotherapy, cellular therapy, virotherapy)
- Health-related quality of life assessment incorporating the social determinants of health (SDOH) specific to mesothelioma patient care, side effect management, mental health care impact on patient and/or caregiver outcomes, and other related topics.
- Novel strategies for screening and early detection
- Novel strategies for risk assessment and prognosis stratification
- Immune mediated complications of immunotherapy in mesothelioma (monitoring, early detection and management)
- Improving personalization of therapies (gender and racial differences, targeted therapies and predictive biomarkers)
- Mechanisms of treatment resistance/failure
- Mesothelioma biology and etiology (disease-defining molecular pathways, cellular biology, and/or tumor microenvironment)
Funding: $125,000 per year
Duration: 2 year
Research Authority due date: 8.12.25
LOI (required) due date: 15.12.25
Full proposal due date: TBD
